1. Home
  2. PLAB vs SNDX Comparison

PLAB vs SNDX Comparison

Compare PLAB & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

HOLD

Current Price

$43.01

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Syndax Pharmaceuticals Inc.

SNDX

Syndax Pharmaceuticals Inc.

HOLD

Current Price

$24.47

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAB
SNDX
Founded
1969
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
PLAB
SNDX
Price
$43.01
$24.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
13
Target Price
$44.33
$38.69
AVG Volume (30 Days)
770.3K
1.5M
Earning Date
05-27-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
9.09
11.56
EPS
0.74
N/A
Revenue
$535,276,000.00
$172,352,000.00
Revenue This Year
$6.70
$107.40
Revenue Next Year
$4.96
$43.28
P/E Ratio
$54.22
N/A
Revenue Growth
18.77
627.84
52 Week Low
$16.59
$8.59
52 Week High
$45.40
$25.59

Technical Indicators

Market Signals
Indicator
PLAB
SNDX
Relative Strength Index (RSI) 62.19 57.39
Support Level $36.32 $19.46
Resistance Level $44.51 $25.38
Average True Range (ATR) 2.51 1.27
MACD 0.33 -0.03
Stochastic Oscillator 89.99 65.52

Price Performance

Historical Comparison
PLAB
SNDX

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Share on Social Networks: